Loo et al. reported that MRI was useful to monitor tumor response during NACT and massive tumor regression was more easily observed in HER2+ and TN tumors than in HR+/HER2– tumors (Loo et al., 2011). The gene discussed is ERBB2; the disease is neoplasm.